Kane Engages Independent Trading Group as Market Maker
Agreement intended to support an orderly market and improve liquidity in Kane Biotech’s common shares WINNIPEG, Manitoba, Oct. 21, 2026 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”), a biotechnology company commercializing and developing technologies and products that address microbial biofilms, today announced that, subject to the approval of the […]
\